trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor.
Open Access
- 1 December 1985
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 260 (29) , 15639-15645
- https://doi.org/10.1016/s0021-9258(17)36306-8
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Specific binding sites for platelet activating factor in human lung tissuesBiochemical and Biophysical Research Communications, 1985
- Platelet-activating factor todayTrends in Pharmacological Sciences, 1983
- More binding, more fancyTrends in Pharmacological Sciences, 1983
- CV-3988 - A specific antagonist of platelet activating factor (PAF)Life Sciences, 1983
- Potent platelet stimulating activity of enantiomers of acetyl glyceryl ether phosphorylcholine and its methoxy analoguesBiochemical and Biophysical Research Communications, 1981
- Novel effects of 1-0-hexadecyl-2-acyl-sn-glycero-3-phosphorylcholine mediators on human leukocyte function: Delineation of the specific roles of the acyl substituentsBiochemical and Biophysical Research Communications, 1980
- Antihypertensive activity of an alkyl ether analog of phosphatidylcholineBiochemical and Biophysical Research Communications, 1979
- Properties of 3H-diazepam binding to benzodiazepine receptors in rat cerebral cortexLife Sciences, 1977
- Estimation of hormone receptor affinity by competitive displacement of labeled ligand: Effect of concentration of receptor and of labeled ligandBiochemical and Biophysical Research Communications, 1975
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973